Lastly, prior studies demonstrated that IGF2 activates PI3K/AKT and MAPK pathways as downstream of IGF2 in osteoarthritis and cancer to promote proliferation, survival, and disease progression 61-63. This evidence concerns the gene AKT1 and cancer.